Reimbursement and coverage implications for CGM

Diabetes Technology and Therapeutics

Volumn 7, Issue 5, 2005, Pages 797-800

  Aubry, Wade ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Health Technology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD GLUCOSE MONITORING; CONFERENCE PAPER; COST; DEVICE; DIABETES MELLITUS; FOOD AND DRUG ADMINISTRATION; HUMAN; INSULIN INFUSION; INSULIN PUMP; MEDICAID; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICARE; NATIONAL HEALTH INSURANCE; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; INSURANCE, HEALTH; MEDICARE; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 27644578717     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.797     Document Type: Conference Paper

References (0)